The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumors
Clinical trial NCT03507543 · COMPLETED
Trial details
- NCT number
- NCT03507543
- Sponsor
- Impact Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-03
- Primary completion
- 2020-09-24
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.